INDIAN DENTAL ACADEMY Leader in continuing dental education www.indiandentalacademy.com
www.indiandentalacademy.com
www.indiandentalacademy.com
Cell Cycle
Cell Cycle Non-Specific Agents
Cell Cycle Specific Agents • Antimetabolites
• Alkylating Agents
• Bleomycin
• Antibiotics
• Podophyllin Alkaloids
•Cisplatin
• Plant Alkaloids
• Nitrosoureas www.indiandentalacademy.com
Resistance to Cytotoxic Drugs
Increased expression of MDR-1 gene for a cell surface glycoprotein, P-glycoprotein MDR-1 gene is involved with drug efflux Drugs that reverse multidrug resistance include verapamil, quinidine, and cyclosporine MDR increases resistance to natural drug products including the anthracyclines, vinca alkaloids, and epipodophyllotoxins www.indiandentalacademy.com
Schematic of P-glycoprotein
www.indiandentalacademy.com
Alkylating Agents Nitrogen Mustards
Ethylenimines
Alkyl Sulfonates
Nitrosoureas
Cyclophosphamide
Thiotepa
Busulfan
Carmustine
Legend Drug Class Sub-class www.indiandentalacademy.com
Prototype Drug
Alkylating Agents Mechanism of Action Alkylate within DNA at the N7 position of guanine Resulting in miscoding through abnormal base-pairing with thymine or in depurination by excision of guanine residues, leading to strand breakage Cross-linking of DNA and ring cleavage may also occur
www.indiandentalacademy.com
Alkylating Agents Mechanism of Action
www.indiandentalacademy.com
Nitrogen Mustards Cyclophosphamide Ifosfamide Mechlorethamine Melphalan Chlorambucil
www.indiandentalacademy.com
Cyclophosphamide Metabolism
www.indiandentalacademy.com
Nitrosoureas Carmustine Lomustine Semustine Streptozocin-naturally occuring sugar containing
M.O.A.- cross-link through alkylation of DNA All cross the blood brain barrier www.indiandentalacademy.com
Alkylating-Related Agents Procarbazine Dacarbazine Altretamine Cisplatin Carboplatin
www.indiandentalacademy.com
Platinum Coordination Complexes
These compounds alkylate N7 of guanine. They cause nephro- and ototoxicity. To counteract the effects of nephrotoxicity, give mannitol as an osmotic diuretic, or induce chloride diuresis with 0.1% NaCl. www.indiandentalacademy.com
Alkylating Agents Toxicity
Bone marrow depression, with leukopenia and thrombocytopenia
Cyclophosphamide/Ifosfamide - hemorrhagic cystitis Reduced
by coadministration with MESNA
Cisplatin/Carboplatin - ototoxic and nephrotoxic Nephrotoxicity
reduced by chloride diuresis and hydration www.indiandentalacademy.com
Alkylating Agents Therapeutic Uses
Used to treat a wide variety of hematologic and solid tumors Thiotepa – ovarian cancer Busulfan – chronic myeloid leukemia Nitrosoureas - brain tumors Streptozocin – insulin-secreting islet cell carcinoma of the pancreas
www.indiandentalacademy.com
Antimetabolites Folic Acid Analogs
Purine Analogs
Pyrimidine Analogs
Methotrexate
Mercaptoguanine
Fluorouracil
Legend Drug Class Sub-class Prototype Drug www.indiandentalacademy.com
Folic Acid Analogs Methotrexate Trimetrexate Pemetrexed
www.indiandentalacademy.com
Folate An essential dietary factor, from which THF cofactors are formed which provide single carbon groups for the synthesis of precursors of DNA and RNA ď Ž To function as a cofactor folate must be reduced by DHFR to THF ď Ž
www.indiandentalacademy.com
Methotrexate Mechanism of Action The enzyme DHFR is the 1º site of action MTX prevents the formation of THF, causing an intracellular deficiency of folate coenzymes and accumulation of the toxic inhibitory substrate, DHF polyglutamate The one carbon transfer reactions for purine and thymidylate synthesis cease, interrupting DNA and RNA synthesis
www.indiandentalacademy.com
Major Enzymatic Reactions Requiring Folates as Substrates* GAR
GAR transformylase
DHF (1) dTMP
AICAR transformylase
AICAR (3) 10-formylTHF
*from Bowen
GMP (2)
Formate + b THF e
Methionine
5,10-CH2THF a
DNA
IMP
AMP
dUMP
c
5-CH3THF
d
Homocysteine
a,thymidylate synthase; b, dihydrofolate reductase; c, methylenetetrahydrofolate reductase; d, methionine synthase;www.indiandentalacademy.com e, serine hydroxymethyl transferase
Resistance
www.indiandentalacademy.com
Methotrexate Mechanism of Resistance 1. 2. 3. 4.
Decreased drug transport Altered DHFR Decreased polyglutamate formation Increased levels of DHFR
www.indiandentalacademy.com
Methotrexate Therapeutic Uses
Methotrexate- psoriasis, rheumatoid arthritis, acute lymphoblastic leukemia, meningeal leukemia, choriocarcinoma, osteosarcoma, mycosis fungoides, Burkitt’s and non-Hodgkin’s lymphomas, cancers of the breast, head and neck, ovary, and bladder www.indiandentalacademy.com
Trimetrexate Therapeutic Uses ď Ž
Trimetrexate- Pneumocystis carinii pneumonia, metastatic colorectal carcinoma, head and neck carcinoma, pancreatic carcinoma, non-small cell carcinoma of the lung
www.indiandentalacademy.com
Pemetrexed Therapeutic Uses ď Ž
Pemetrexed- Mesothelioma
www.indiandentalacademy.com
Methotrexate Toxicity
Bone marrow suppression Rescue
with leucovorin (folinic acid)
Nephrotoxic give
sodium bicarbonate to alkalinize the urine
www.indiandentalacademy.com
Purine Antagonists Mercaptopurine Thioguanine Fludarabine Phosphate Cladribine
www.indiandentalacademy.com
Mercaptopurine/Thioguanine Must metabolized by HGPRT to the nucleotide form ď Ž This form inhibits numerous enzymes of purine nucleotide interconversion ď Ž
www.indiandentalacademy.com
Fludarabine Phosphate M.O.A.- phosphorylated intracellularly by deoxycytidine kinase to the triphosphate form The metabolite inhibits DNA polymerase-α and ribonucleotide reductase Induces apoptosis Tx- non-Hodgkin’s lymphoma and chronic lymphocytic leukemia
www.indiandentalacademy.com
Cladribine M.O.A. -phosphorylated by deoxycytidine kinase and is incorporated into DNA Causes DNA strand breaks Tx- hairy cell leukemia, chronic lymphocytic leukemia, and non-Hodgkin’s lymphoma
www.indiandentalacademy.com
Pyrimidine Antagonists Fluorouracil - S-phase Cytarabine Gemcitabine Capecitabine
www.indiandentalacademy.com
MTX
X
5-FU
X
Figure 2. This figure illustrates the effects of MTX and 5-FU on the biochemical pathway for reduced folates. www.indiandentalacademy.com
Mechanism of Action 5-FU
5-FU inhibits thymidylate synthase therefore causing depletion of Thymidylate
5-FU is incorporated into DNA
5-FU inhibits RNA processing www.indiandentalacademy.com
Activation of 5-FU
www.indiandentalacademy.com
Therapeutic Uses of 5-FU Metastatic carcinomas of the breast and the GI tract hepatoma carcinomas of the ovary, cervix, urinary bladder, prostate, pancreas, and oropharyngeal areas Combined with levamisole for Tx of colon cancer
www.indiandentalacademy.com
Cytarabine It is activated to 5’ monophosphate (AraCMP) by deoxycytidine kinase Through a series of reactions it forms the diphosphate (AraCDP) and triphosphate (AraCTP) nucleotides Accumulation of AraCTP potently inhibits DNA synthesis Inhibition of DNA synthesis is due to competitive (-) of polymerases and interference of chain elongation
www.indiandentalacademy.com
Cytarabine It is a potent inducer of tumor cell differentiation Fragmentation of DNA and evidence of apoptosis is noticed in treated cells AraC is cell-cycle specific agent, it kills cells in the S-phase
www.indiandentalacademy.com
Cytarabine Mechanisms of Resistance deficiency of deoxycytidine kinase increased CTP synthase activity increased cytidine deaminase activity decreased affinity of DNA polymerase for AraCTP decrease ability of the cell to transport AraC
www.indiandentalacademy.com
Cytarabine Therapeutic Uses Induction of remissions in acute leukemia Treats meningeal leukemia Treatment of acute nonlymphocytic leukemia In combination with anthracyclines or mitoxantrone it can treat non-Hodgkin’s lymphomas
www.indiandentalacademy.com
Cytarabine Toxicities Nausea acute myelosuppression stomatitis alopecia
www.indiandentalacademy.com
Gemcitabine Gemcitabine is S-phase specific it is a deoxycytidine antimetabolite it undergoes intracellular conversion to gemcitabine monophosphate via the enzyme deoxycytidine kinase it is subsequently phosphorylated to gemcitabine diphosphate and gemcitabine triphosphate
www.indiandentalacademy.com
Gemcitabine Gemcitabine triphosphate competes with deoxycytidine triphosphate (dCTP) for incorporation into DNA strands do to an addition of a base pair before DNA polymerase is stopped, Gemcitabine inhibits both DNA replication and repair Gemcitabine-induced cell death has characteristics of apoptosis
www.indiandentalacademy.com
Gemcitabine Therapeutic Uses Gemcitabine treats a variety of solid tumors very effective in the treatment of pancreatic cancer small cell lung cancer carcinoma of the bladder, breast, kidney, ovary, and head and neck
www.indiandentalacademy.com
Cancer Chemotherapy Jillian H. Davis Department of Pharmacology Howard University www.indiandentalacademy.com
Plant Alkaloids Vinca Alkaloids
Podophyllotoxins
Camptothecins
Taxanes
Vinblastine
Etoposide
Topotecan
Paclitaxel
www.indiandentalacademy.com
Vinca Alkaloids
Vinblastine Vincristine Vinorelbine
www.indiandentalacademy.com
Vinca Alkaloids
Inhibit microtubules (spindle), causing metaphase cell arrest in M phase. 3 3
www.indiandentalacademy.com
Vinca Alkaloids Mechanism of Action
Binds to the microtubular protein tubulin in a dimeric form The drug-tubulin complex adds to the forming end of the microtubules to terminate assembly Depolymerization of the microtubules occurs Resulting in mitotic arrest at metaphase, dissolution of the mitotic spindle, and interference with chromosome segregation CCS agents- M phase www.indiandentalacademy.com
Vinblastine Toxicity Nausea Vomiting Marrow depression Alopecia
www.indiandentalacademy.com
Vinblastine Therapeutic Uses Systemic Hodgkin’s disease Lymphomas
www.indiandentalacademy.com
Vincristine Toxicity Muscle weakness Peripheral neuritis
www.indiandentalacademy.com
Vincristine Therapeutic Uses ď Ž
With prednisone for remission of Acute Leukemia
www.indiandentalacademy.com
Vinorelbine Toxicity ď Ž
Granulocytopenia
Therapeutic Uses ď Ž
non-small cell lung cancer
www.indiandentalacademy.com
Podophyllotoxins
Etoposide (VP-16) Teniposide (VM-26)
Semi-synthetic derivatives of podophyllotoxin extracted from the root of the www.indiandentalacademy.com mayapple
Podophyllotoxins Mechanism of Action Blocks cells in the late S-G2 phase of the cell cycle through inhibition of topoisomerase II ď Ž Resulting in DNA damage through strand breakage induced by the formation of a ternary complex of drug, DNA, and enzyme ď Ž
www.indiandentalacademy.com
Podophyllotoxins Toxicity
Nausea Vomiting Alopecia Hematopoietic and lymphoid toxicity
www.indiandentalacademy.com
Podophyllotoxins Therapeutic Uses Monocytic Leukemia Testicular cancer Oat cell carcinoma of the lung
www.indiandentalacademy.com
Camptothecins ď Ž ď Ž
Topotecan Irinotecan
www.indiandentalacademy.com
Camptothecins Mechanism of Action Interfere with the activity of Topoisomerase I Resulting in DNA damage
Irinotecan- a prodrug that is metabolized to an active Top I inhibitor, SN-38
www.indiandentalacademy.com
Camptothecins Toxicity
Topotecan Neutropenia,
thrombocytopenia, anemia
Irinotecan Severe
diarrhea, myelosuppression
www.indiandentalacademy.com
Camptothecins Therapeutic Uses Topotecan- metastatic ovarian cancer (cisplatin-resistant) ď Ž Irinotecan- colon and rectal cancer ď Ž
www.indiandentalacademy.com
Taxanes Paclitaxel (Taxol) Docetaxel
Alkaloid esters derived from the Western and European Yew www.indiandentalacademy.com
Taxanes Mechanism of Action
Mitotic “spindle poison” through the enhancement of tubulin polymerization
www.indiandentalacademy.com
Taxanes Toxicity
Paclitaxel Neutropenia,
thrombocytopenia Peripheral neuropathy
Docetaxel Bone
marrow suppression Neurotoxicity Fluid retention www.indiandentalacademy.com
Taxanes Therapeutic Uses Paclitaxel- ovarian and advanced breast cancer ď Ž Docetaxel- advanced breast cancer ď Ž
www.indiandentalacademy.com
Antibiotics Anthracyclines- Doxorubicin & Daunorubicin Dactinomycin Plicamycin Mitomycin Bleomycin
www.indiandentalacademy.com
Anthracyclines Doxorubicin Daunorubicin
www.indiandentalacademy.com
Anthracyclines Mechanism of Action High-affinity binding to DNA through intercalation, resulting in blockade of DNA and RNA synthesis DNA strand scission via effects on Top II Binding to membranes altering fluidity Generation of the semiquinone free radical and oxygen radicals
www.indiandentalacademy.com
Anthracyclines Toxicity Bone marrow depression Total alopecia Cardiac toxicity
www.indiandentalacademy.com
Anthracyclines Therapeutic Uses
Doxorubicin- carcinomas of the breast, endometrium, ovary, testicle, thyroid, and lung, Ewing’s sarcoma, and osteosarcoma
Daunorubicin- acute leukemia
www.indiandentalacademy.com
Dactinomycin Mechanism of Action Binds to double stranded DNA through intercalation between adjacent guaninecytosine base pairs ď Ž Inhibits all forms of DNA-dependent RNA synthesis ď Ž
www.indiandentalacademy.com
Dactinomycin Toxicity Bone marrow depression Oral ulcers Skin eruptions Immunosuppression
www.indiandentalacademy.com
Dactinomycin Therapeutic Uses Wilms’ tumors Gestational choriocarinoma with MTX
www.indiandentalacademy.com
Plicamycin Mechanism of Action Binds to DNA through an antibiotic-Mg 2+ complex This interaction interrupts DNA-directed RNA synthesis
www.indiandentalacademy.com
Plicamycin Toxicity Hypocalcemia Bleeding disorders Liver toxicity
www.indiandentalacademy.com
Plicamycin Therapeutic Uses Testicular cancer Hypercalcemia
www.indiandentalacademy.com
Mitomycin Mechanism of Action ď Ž
Bioreductive alkylating agent that undergoes metabolic reductive activation through an enzyme-mediated reduction to generate an alkylating agent that crosslinks DNA
www.indiandentalacademy.com
Mitomycin Toxicity Severe myelosuppression Renal toxicity Interstitial pneumonitis
www.indiandentalacademy.com
Mitomycin Therapeutic Uses Squamous cell carcinoma of the cervix Adenocarcinomas of the stomach, pancreas, and lung 2nd line in metastatic colon cancer
www.indiandentalacademy.com
Bleomycin Acts through binding to DNA, which results in single and double strand breaks following free radical formation and inhibition of DNA synthesis The DNA fragmentation is due to oxidation of a DNA-bleomycin-Fe(II) complex and leads to chromosomal aberrations CCS drug that causes accumulation of cells in G2
www.indiandentalacademy.com
Bleomycin Toxicity Lethal anaphylactoid reactions Blistering Pulmonary fibrosis
www.indiandentalacademy.com
Bleomycin Therapeutic Uses Testicular cancer Squamous cell carcinomas of the head and neck, cervix, skin, penis, and rectum Lymphomas Intracavitary therapy in ovarian and breast cancers
www.indiandentalacademy.com
Hormonal Agents Estrogen & Androgen Inhibitors
Tamoxifen
Gonadotropin-Releasing Aromatase Inhibitors Hormone Agonists
Leuprolide
Aminogluthethimide
Legend Drug Class Sub-class Prototype Drug www.indiandentalacademy.com
Anti-Estrogens Tamoxifen (SERMs) Raloxifene (SERMs) Faslodex
www.indiandentalacademy.com
Tamoxifen
Selective estrogen receptor modulator (SERM), have both estrogenic and antiestrogenic effects on various tissues Binds to estrogen receptors (ER) and induces conformational changes in the receptor Has antiestrogenic effects on breast tissue. The ability to produce both estrogenic and antiestrogenic affects is most likely due to the interaction with other coactivators or corepressors in the tissue and the binding with different estrogen receptors, ERα and ERβ Subsequent to tamoxifen ER binding, the expression of estrogen dependent genes is blocked or altered Resulting in decreased estrogen response. Most of tamoxifen’s affects occur in the G1 phase of the cell cycle www.indiandentalacademy.com
Tamoxifen Toxicity Hot flashes Fluid retention nausea
www.indiandentalacademy.com
Tamoxifen Therapeutic Uses
Tamoxifen can be used as primary therapy for metastatic breast cancer in both men and postmenopausal women
Patients with estrogen-receptor (ER) positive tumors are more likely to respond to tamoxifen therapy, while the use of tamoxifen in women with ER negative tumors is still investigational
When used prophylatically, tamoxifen has been shown to decrease the incidence of breast cancer in women who are at high risk for www.indiandentalacademy.com developing the disease
Anti-Androgen
Flutamide Antagonizes
androgenic effects approved for the treatment of prostate cancer
www.indiandentalacademy.com
Gonadotropoin-Releasing Hormone Agonists Leuprolide ď Ž Goserelin ď Ž
www.indiandentalacademy.com
Gonadotropoin-Releasing Hormone Agonist Mechanism of Action Agents act as GnRH agonist, with paradoxic effects on the pituitary Initially stimulating the release of FSH and LH, followed by inhibition of the release of these hormones Resulting in reduced testicular androgen synthesis
www.indiandentalacademy.com
Gonadotropoin-Releasing Hormone Agonist Toxicity Gynecomastia Edema thromboembolism
www.indiandentalacademy.com
Gonadotropoin-Releasing Hormone Agonist Therapeutic Uses Metastatic carcinoma of the prostate ď Ž Hormone receptor-positive breast cancer ď Ž
www.indiandentalacademy.com
Aromatase Inhibitors Aminogluthethimide ď Ž Anastrozole ď Ž
www.indiandentalacademy.com
Aminogluthethimide Mechanism of Action Inhibitor of adrenal steroid synthesis at the first step, conversion of cholesterol of pregnenolone ď Ž Inhibits the extra-adrenal synthesis of estrone and estradiol ď Ž Inhibits the enzyme aromatase that converts androstenedione to estrone ď Ž
www.indiandentalacademy.com
www.indiandentalacademy.com
Aminogluthethimide Toxicity Dizziness Lethargy Visual blurring Rash Therapeutic Uses
ER- and PR-positive metastatic breast cancer www.indiandentalacademy.com
Anastrozole A new selective nonsteroidal inhibitor of aromatase ď Ž Treats advanced estrogen and progesterone receptor positive breast cancer that is no longer responsive to tamoxifen ď Ž
www.indiandentalacademy.com
Miscellaneous AntiCancer Agents Asparaginase Hydroxurea Mitoxantrone Mitotane Retinoic Acid Derivatives Amifostine
www.indiandentalacademy.com
Asparaginase An enzyme isolated from bacteria Causes catabolic depletion of serum asparagine to aspartic acid and ammonia Resulting in reduced blood glutamine levels and inhibition of protein synthesis Neoplastic cells require external source of asparagine Treats childhood acute leukemia Can cause anaphylactic shock
www.indiandentalacademy.com
Hydroxyurea An analog of urea Inhibits the enzyme ribonucleotide reductase Resulting in the depletion of deoxynucleoside triphosphate pools Thereby inhibiting DNA synthesis S-phase specific agent Treats melanoma and chronic myelogenous leukemia
www.indiandentalacademy.com
Mitoxantrone Structure resembles the anthracyclines Binds to DNA to produce strand breakage Inhibits DNA and RNA synthesis Treats pediatric and adult acute myelogenous leukemia, non-Hodgkin’s lymphomas, and breast cancer Causes cardiac toxicity
www.indiandentalacademy.com
Mechanisms & Actions of Useful Chemotherapeutic Drugs in Neoplastic Disease
www.indiandentalacademy.com
www.indiandentalacademy.com Leader in continuing dental education
www.indiandentalacademy.com